Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

Gorde:

Xehetasun bibliografikoak
Argitaratua izan da:	Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
Egile nagusia:	Khan, Mohd Shahnawaz
Beste egile batzuk:	Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
Argitaratua:	Nature Publishing Group
Gaiak:	Food & Drug Administration > FDA Cancer PD-L1 protein Binders Bioinformatics Therapeutic targets Binding sites Biological products Drug development Computer applications Molecular dynamics Efficiency Proteins Simulation Principal components analysis FDA approval Immune checkpoint Antineoplastic drugs Pharmacokinetics Ligands Immunosuppressive agents Cancer therapies Environmental
Sarrera elektronikoa:	Citation/Abstract Full Text Full Text - PDF
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Izan zaitez lehena ohar bat uzten!